Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment
Clinical trial NCT03446001 · COMPLETED
Trial details
- NCT number
- NCT03446001
- Sponsor
- TauRx Therapeutics Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2022-03-31
- Enrollment
- 598
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.